Middle East Healthcare Co. (MEAHCO), which owns and operates the Saudi German Hospital chain, reported net profit after Zakat and tax of SAR 21.2 million, surging 45% year-on-year (YoY) for Q1 2020, compared to SAR 14.6 million in the same period last year.
Item | Q1 2019 | Q1 2020 | Change |
---|---|---|---|
Revenues | 350.18 | 436.31 | 24.6 % |
Gross Income | 101.63 | 146.86 | 44.5 % |
Operating Income | 18.31 | 24.36 | 33.0 % |
Net Income | 14.59 | 21.18 | 45.2 % |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | 0.16 | 0.23 | 45.2 % |
Item | Q4 2019 | Q1 2020 | Change |
---|---|---|---|
Revenues | 406.51 | 436.31 | 7.3 % |
Gross Income | 148.59 | 146.86 | (1.2 %) |
Operating Income | 44.06 | 24.36 | (44.7 %) |
Net Income | 37.47 | 21.18 | (43.5 %) |
Average Shares | 92.04 | 92.04 | - |
EPS (Riyals) | 0.41 | 0.23 | (43.5 %) |
The company attributed the increase to higher revenue due to rise in patient traffic, and lower cost of revenue.
On a quarterly basis, Q1 earnings decreased 43.4% on higher cost of revenue and general and administrative expenses, increased credit losses provision on COVID-19, and SAR 19 million losses from the recent commencement of operations at Dammam hospital.
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2011 | - | - | - | - | - | - |
Q2 2011 | - | - | - | - | - | - |
Q3 2011 | - | - | - | - | - | - |
Q4 2011 | - | - | - | - | - | - |
2011 | 436.84 | - | 159.99 | - | 40.98 | - |
Q1 2012 | - | - | - | - | - | - |
Q2 2012 | - | - | - | - | - | - |
Q3 2012 | - | - | - | - | - | - |
Q4 2012 | - | - | - | - | - | - |
2012 | 542.22 | 24.1 % | 248.36 | 55.2 % | 72.56 | 77.0 % |
Q1 2013 | - | - | - | - | - | - |
Q2 2013 | - | - | - | - | - | - |
Q3 2013 | - | - | - | - | - | - |
Q4 2013 | - | - | - | - | - | - |
2013 | 828.36 | 52.8 % | 430.49 | 73.3 % | 136.85 | 88.6 % |
Q1 2014 | 359.18 | - | 199.49 | - | 75.11 | - |
Q2 2014 | 347.08 | - | 185.78 | - | 88.17 | - |
Q3 2014 | 323.16 | - | 174.49 | - | 71.53 | - |
Q4 2014 | 369.34 | - | 190.01 | - | 78.37 | - |
2014 | 1,398.75 | 68.9 % | 749.76 | 74.2 % | 313.18 | 128.8 % |
Q1 2015 | 391.64 | 9.0 % | 208.99 | 4.8 % | 102.89 | 37.0 % |
Q2 2015 | 372.00 | 7.2 % | 203.88 | 9.7 % | 89.24 | 1.2 % |
Q3 2015 | 352.20 | 9.0 % | 183.23 | 5.0 % | 88.21 | 23.3 % |
Q4 2015 | 418.69 | 13.4 % | 214.04 | 12.6 % | 97.86 | 24.9 % |
2015 | 1,534.53 | 9.7 % | 810.13 | 8.1 % | 378.20 | 20.8 % |
Q1 2016 | 421.52 | 7.6 % | 216.62 | 3.7 % | 103.68 | 0.8 % |
Q2 2016 | 410.07 | 10.2 % | 212.49 | 4.2 % | 76.56 | (14.2 %) |
Q3 2016 | 379.09 | 7.6 % | 199.40 | 8.8 % | 91.10 | 3.3 % |
Q4 2016 | 404.96 | (3.3 %) | 199.88 | (6.6 %) | 87.04 | (11.1 %) |
2016 | 1,615.64 | 5.3 % | 828.39 | 2.3 % | 358.37 | (5.2 %) |
Q1 2017 | 393.53 | (6.6 %) | 180.47 | (16.7 %) | 107.04 | 3.2 % |
Q2 2017 | 351.28 | (14.3 %) | 138.63 | (34.8 %) | 58.97 | (23.0 %) |
Q3 2017 | 352.98 | (6.9 %) | 133.30 | (33.1 %) | 55.70 | (38.9 %) |
Q4 2017 | 364.60 | (10.0 %) | 145.47 | (27.2 %) | 73.06 | (16.1 %) |
2017 | 1,462.39 | (9.5 %) | 597.87 | (27.8 %) | 294.77 | (17.7 %) |
Q1 2018 | 395.11 | 0.4 % | 160.42 | (11.1 %) | 85.82 | (19.8 %) |
Q2 2018 | 346.13 | (1.5 %) | 116.91 | (15.7 %) | 31.66 | (46.3 %) |
Q3 2018 | 338.77 | (4.0 %) | 111.87 | (16.1 %) | 21.29 | (61.8 %) |
Q4 2018 | 310.68 | (14.8 %) | 111.56 | (23.3 %) | 23.96 | (67.2 %) |
2018 | 1,390.69 | (4.9 %) | 500.75 | (16.2 %) | 162.73 | (44.8 %) |
Q1 2019 | 350.18 | (11.4 %) | 101.63 | (36.6 %) | 18.31 | (78.7 %) |
Q2 2019 | 353.20 | 2.0 % | 102.76 | (12.1 %) | 7.58 | (76.0 %) |
Q3 2019 | 386.76 | 14.2 % | 119.96 | 7.2 % | 33.31 | 56.5 % |
Q4 2019 | 406.51 | 30.8 % | 148.59 | 33.2 % | 44.06 | 83.9 % |
2019 | 1,496.65 | 7.6 % | 472.93 | (5.6 %) | 103.27 | (36.5 %) |
Q1 2020 | 436.31 | 24.6 % | 146.86 | 44.5 % | 24.36 | 33.0 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2010 | - | - | - | - | - | - |
2011 | 436.84 | - | 159.99 | - | 40.98 | - |
2012 | 542.22 | 24.1 % | 248.36 | 55.2 % | 72.56 | 77.0 % |
2013 | 828.36 | 52.8 % | 430.49 | 73.3 % | 136.85 | 88.6 % |
2014 | 1,398.75 | 68.9 % | 749.76 | 74.2 % | 313.18 | 128.8 % |
2015 | 1,534.53 | 9.7 % | 810.13 | 8.1 % | 378.20 | 20.8 % |
2016 | 1,615.64 | 5.3 % | 828.39 | 2.3 % | 358.37 | (5.2 %) |
2017 | 1,462.39 | (9.5 %) | 597.87 | (27.8 %) | 294.77 | (17.7 %) |
2018 | 1,390.69 | (4.9 %) | 500.75 | (16.2 %) | 162.73 | (44.8 %) |
2019 | 1,496.65 | 7.6 % | 472.93 | (5.6 %) | 103.27 | (36.5 %) |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2011 | - | - | - | - | - | - |
Q2 2011 | - | - | - | - | - | - |
Q3 2011 | - | - | - | - | - | - |
Q4 2011 | - | - | - | - | - | - |
2011 | 36.01 | - | 0.39 | - | 36.01 | 0.39 |
Q1 2012 | - | - | - | - | - | - |
Q2 2012 | - | - | - | - | - | - |
Q3 2012 | - | - | - | - | - | - |
Q4 2012 | - | - | - | - | - | - |
2012 | 61.99 | 72.2 % | 0.67 | - | 61.99 | 0.67 |
Q1 2013 | - | - | - | - | - | - |
Q2 2013 | - | - | - | - | - | - |
Q3 2013 | - | - | - | - | - | - |
Q4 2013 | - | - | - | - | - | - |
2013 | 137.20 | 121.3 % | 1.49 | - | 137.20 | 1.49 |
Q1 2014 | 80.16 | - | 0.87 | - | 80.16 | 0.87 |
Q2 2014 | 92.80 | - | 1.01 | - | 92.80 | 1.01 |
Q3 2014 | 74.36 | - | 0.81 | - | 74.36 | 0.81 |
Q4 2014 | 84.64 | - | 0.92 | - | 84.64 | 0.92 |
2014 | 331.97 | 142.0 % | 3.61 | - | 331.97 | 3.61 |
Q1 2015 | 105.39 | 31.5 % | 1.15 | - | 105.39 | 1.15 |
Q2 2015 | 91.79 | (1.1 %) | 1.00 | - | 91.79 | 1.00 |
Q3 2015 | 90.75 | 22.0 % | 0.99 | - | 90.75 | 0.99 |
Q4 2015 | 102.32 | 20.9 % | 1.11 | - | 102.32 | 1.11 |
2015 | 390.25 | 17.6 % | 4.24 | - | 390.25 | 4.24 |
Q1 2016 | 104.20 | (1.1 %) | 1.13 | - | 104.20 | 1.13 |
Q2 2016 | 74.07 | (19.3 %) | 0.80 | - | 74.07 | 0.80 |
Q3 2016 | 99.64 | 9.8 % | 1.08 | - | 99.64 | 1.08 |
Q4 2016 | 84.73 | (17.2 %) | 0.92 | - | 84.73 | 0.92 |
2016 | 362.64 | (7.1 %) | 3.94 | - | 362.64 | 3.94 |
Q1 2017 | 109.97 | 5.5 % | 1.19 | - | 109.97 | 1.19 |
Q2 2017 | 61.95 | (16.4 %) | 0.67 | - | 61.95 | 0.67 |
Q3 2017 | 64.88 | (34.9 %) | 0.70 | - | 64.88 | 0.70 |
Q4 2017 | 82.69 | (2.4 %) | 0.90 | - | 82.69 | 0.90 |
2017 | 319.49 | (11.9 %) | 3.47 | - | 319.49 | 3.47 |
Q1 2018 | 87.13 | (20.8 %) | 0.95 | - | 87.13 | 0.95 |
Q2 2018 | 34.27 | (44.7 %) | 0.37 | - | 34.27 | 0.37 |
Q3 2018 | 20.16 | (68.9 %) | 0.22 | - | 20.16 | 0.22 |
Q4 2018 | 30.69 | (62.9 %) | 0.33 | - | 30.69 | 0.33 |
2018 | 172.25 | (46.1 %) | 1.87 | - | 172.25 | 1.87 |
Q1 2019 | 14.59 | (83.3 %) | 0.16 | - | 14.59 | 0.16 |
Q2 2019 | 12.28 | (64.2 %) | 0.13 | - | 12.28 | 0.13 |
Q3 2019 | 33.23 | 64.8 % | 0.36 | - | 33.23 | 0.36 |
Q4 2019 | 37.47 | 22.1 % | 0.41 | (8.00) | 45.47 | 0.49 |
2019 | 97.57 | (43.4 %) | 1.06 | (8.00) | 105.57 | 1.15 |
Q1 2020 | 21.18 | 45.2 % | 0.23 | - | 21.18 | 0.23 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2010 | - | - | - | - | - | - |
2011 | 36.01 | - | 0.39 | - | 36.01 | 0.39 |
2012 | 61.99 | 72.2 % | 0.67 | - | 61.99 | 0.67 |
2013 | 137.20 | 121.3 % | 1.49 | - | 137.20 | 1.49 |
2014 | 331.97 | 142.0 % | 3.61 | - | 331.97 | 3.61 |
2015 | 390.25 | 17.6 % | 4.24 | - | 390.25 | 4.24 |
2016 | 362.64 | (7.1 %) | 3.94 | - | 362.64 | 3.94 |
2017 | 319.49 | (11.9 %) | 3.47 | - | 319.49 | 3.47 |
2018 | 172.25 | (46.1 %) | 1.87 | - | 172.25 | 1.87 |
2019 | 97.57 | (43.4 %) | 1.06 | (8.00) | 105.57 | 1.15 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
2011 | 36.62 % | 20.91 % | 8.24 % |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
2012 | 45.80 % | 20.53 % | 11.43 % |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
2013 | 51.97 % | 21.68 % | 16.56 % |
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | 53.60 % | 25.57 % | 23.73 % |
2014 | 53.60 % | 25.57 % | 23.73 % |
Q1 2015 | 53.05 % | 27.10 % | 24.96 % |
Q2 2015 | 53.39 % | 26.84 % | 24.46 % |
Q3 2015 | 52.93 % | 27.56 % | 25.09 % |
Q4 2015 | 52.79 % | 28.05 % | 25.43 % |
2015 | 52.79 % | 28.05 % | 25.43 % |
Q1 2016 | 52.27 % | 27.77 % | 24.87 % |
Q2 2016 | 51.57 % | 26.50 % | 23.17 % |
Q3 2016 | 51.71 % | 26.41 % | 23.34 % |
Q4 2016 | 51.27 % | 26.12 % | 22.45 % |
2016 | 51.27 % | 26.12 % | 22.45 % |
Q1 2017 | 49.90 % | 26.91 % | 23.20 % |
Q2 2017 | 46.99 % | 27.02 % | 23.30 % |
Q3 2017 | 43.41 % | 25.39 % | 21.40 % |
Q4 2017 | 40.88 % | 25.40 % | 21.85 % |
2017 | 40.88 % | 25.40 % | 21.85 % |
Q1 2018 | 39.47 % | 24.17 % | 20.26 % |
Q2 2018 | 38.12 % | 22.54 % | 18.44 % |
Q3 2018 | 37.01 % | 20.57 % | 15.52 % |
Q4 2018 | 36.01 % | 18.10 % | 12.39 % |
2018 | 36.01 % | 18.10 % | 12.39 % |
Q1 2019 | 32.84 % | 13.74 % | 7.41 % |
Q2 2019 | 31.62 % | 12.25 % | 5.74 % |
Q3 2019 | 31.12 % | 12.85 % | 6.48 % |
Q4 2019 | 31.60 % | 13.48 % | 7.05 % |
2019 | 31.60 % | 13.48 % | 7.05 % |
Q1 2020 | 32.74 % | 13.41 % | 7.09 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2010 | - | - | - |
2011 | 36.62 % | 20.91 % | 8.24 % |
2012 | 45.80 % | 20.53 % | 11.43 % |
2013 | 51.97 % | 21.68 % | 16.56 % |
2014 | 53.60 % | 25.57 % | 23.73 % |
2015 | 52.79 % | 28.05 % | 25.43 % |
2016 | 51.27 % | 26.12 % | 22.45 % |
2017 | 40.88 % | 25.40 % | 21.85 % |
2018 | 36.01 % | 18.10 % | 12.39 % |
2019 | 31.60 % | 13.48 % | 7.05 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
Q1 2014 | 55.54 % | 23.76 % | 22.32 % |
Q2 2014 | 53.53 % | 28.54 % | 26.74 % |
Q3 2014 | 54.00 % | 25.72 % | 23.01 % |
Q4 2014 | 51.45 % | 24.43 % | 22.92 % |
Q1 2015 | 53.36 % | 29.47 % | 26.91 % |
Q2 2015 | 54.81 % | 27.44 % | 24.67 % |
Q3 2015 | 52.02 % | 28.83 % | 25.77 % |
Q4 2015 | 51.12 % | 26.62 % | 24.44 % |
Q1 2016 | 51.39 % | 28.30 % | 24.72 % |
Q2 2016 | 51.82 % | 22.50 % | 18.06 % |
Q3 2016 | 52.60 % | 28.28 % | 26.29 % |
Q4 2016 | 49.36 % | 25.48 % | 20.92 % |
Q1 2017 | 45.86 % | 31.64 % | 27.94 % |
Q2 2017 | 39.46 % | 22.25 % | 17.64 % |
Q3 2017 | 37.76 % | 21.46 % | 18.38 % |
Q4 2017 | 39.90 % | 25.53 % | 22.68 % |
Q1 2018 | 40.60 % | 27.04 % | 22.05 % |
Q2 2018 | 33.78 % | 15.35 % | 9.90 % |
Q3 2018 | 33.02 % | 13.01 % | 5.95 % |
Q4 2018 | 35.91 % | 15.33 % | 9.88 % |
Q1 2019 | 29.02 % | 11.44 % | 4.17 % |
Q2 2019 | 29.09 % | 9.62 % | 3.48 % |
Q3 2019 | 31.02 % | 15.07 % | 8.59 % |
Q4 2019 | 36.55 % | 17.05 % | 11.18 % |
Q1 2020 | 33.66 % | 11.59 % | 4.85 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2011 | - | - | - | - |
Q2 2011 | - | - | - | - |
Q3 2011 | - | - | - | - |
Q4 2011 | - | - | - | - |
Q1 2012 | - | - | - | - |
Q2 2012 | - | - | - | - |
Q3 2012 | - | - | - | - |
Q4 2012 | - | - | - | - |
Q1 2013 | - | - | - | - |
Q2 2013 | - | - | - | - |
Q3 2013 | - | - | - | - |
Q4 2013 | - | - | - | - |
Q1 2014 | 92.04 | - | - | 10.70 |
Q2 2014 | 92.04 | - | - | 11.69 |
Q3 2014 | 92.04 | - | - | 12.48 |
Q4 2014 | 92.04 | 3.61 | 3.61 | 12.38 |
Q1 2015 | 92.04 | 3.88 | 3.88 | 13.50 |
Q2 2015 | 92.04 | 3.87 | 3.87 | 12.67 |
Q3 2015 | 92.04 | 4.05 | 4.05 | 13.63 |
Q4 2015 | 92.04 | 4.24 | 4.24 | 14.70 |
Q1 2016 | 92.04 | 4.23 | 4.23 | 16.39 |
Q2 2016 | 92.04 | 4.03 | 4.03 | 15.20 |
Q3 2016 | 92.04 | 4.13 | 4.13 | 16.43 |
Q4 2016 | 92.04 | 3.94 | 3.94 | 17.32 |
Q1 2017 | 92.04 | 4.00 | 4.00 | 18.46 |
Q2 2017 | 92.04 | 3.87 | 3.87 | 17.09 |
Q3 2017 | 92.04 | 3.49 | 3.49 | 17.74 |
Q4 2017 | 92.04 | 3.47 | 3.47 | 15.75 |
Q1 2018 | 92.04 | 3.22 | 3.22 | 16.69 |
Q2 2018 | 92.04 | 2.92 | 2.92 | 15.07 |
Q3 2018 | 92.04 | 2.44 | 2.44 | 15.29 |
Q4 2018 | 92.04 | 1.87 | 1.87 | 15.71 |
Q1 2019 | 92.04 | 1.08 | 1.08 | 15.87 |
Q2 2019 | 92.04 | 0.84 | 0.84 | 16.00 |
Q3 2019 | 92.04 | 0.99 | 0.99 | 16.36 |
Q4 2019 | 92.04 | 1.06 | 1.15 | 16.54 |
Q1 2020 | 92.04 | 1.13 | 1.22 | 16.77 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2010 | - | - | - | - |
2011 | 92.04 | 0.39 | 0.39 | 6.03 |
2012 | 92.04 | 0.67 | 0.67 | 6.65 |
2013 | 92.04 | 1.49 | 1.49 | 9.84 |
2014 | 92.04 | 3.61 | 3.61 | 12.38 |
2015 | 92.04 | 4.24 | 4.24 | 14.70 |
2016 | 92.04 | 3.94 | 3.94 | 17.32 |
2017 | 92.04 | 3.47 | 3.47 | 15.75 |
2018 | 92.04 | 1.87 | 1.87 | 15.71 |
2019 | 92.04 | 1.06 | 1.15 | 16.54 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | - | - | - |
Q4 2014 | - | - | - |
Q1 2015 | - | - | - |
Q2 2015 | - | - | - |
Q3 2015 | - | - | - |
Q4 2015 | - | - | - |
Q1 2016 | 17.17 | 17.17 | 4.43 |
Q2 2016 | 17.16 | 17.16 | 4.56 |
Q3 2016 | 12.41 | 12.41 | 3.12 |
Q4 2016 | 18.62 | 18.62 | 4.23 |
Q1 2017 | 18.48 | 18.48 | 4.01 |
Q2 2017 | 19.45 | 19.45 | 4.41 |
Q3 2017 | 17.98 | 17.98 | 3.54 |
Q4 2017 | 15.52 | 15.52 | 3.42 |
Q1 2018 | 17.90 | 17.90 | 3.46 |
Q2 2018 | 20.02 | 20.02 | 3.88 |
Q3 2018 | 15.00 | 15.00 | 2.39 |
Q4 2018 | 17.34 | 17.34 | 2.07 |
Q1 2019 | 29.49 | 29.49 | 2.01 |
Q2 2019 | 32.63 | 32.63 | 1.72 |
Q3 2019 | 26.36 | 26.36 | 1.59 |
Q4 2019 | 28.02 | 25.89 | 1.80 |
Q1 2020 | 22.49 | 20.89 | 1.52 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2010 | - | - | - |
2011 | - | - | - |
2012 | - | - | - |
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | 18.62 | 18.62 | 4.23 |
2017 | 15.52 | 15.52 | 3.42 |
2018 | 17.34 | 17.34 | 2.07 |
2019 | 28.02 | 25.89 | 1.80 |
Q1 2020
2020
Period | Inpatient clinics | Outpatient clinics | Pharmacy Sales | Others |
---|---|---|---|---|
Q1 2014 | 207.07 | 85.01 | 64.94 | 2.16 |
Q2 2014 | 200.50 | 77.40 | 66.66 | 2.51 |
Q1 2015 | 224.99 | 91.95 | 70.24 | 4.46 |
Q2 2015 | 211.41 | 86.64 | 70.30 | 3.65 |
Q3 2015 | 200.38 | 85.53 | 63.54 | 2.76 |
Q4 2015 | 220.47 | 119.55 | 72.94 | 5.72 |
Q1 2016 | 241.22 | 100.20 | 73.04 | 7.06 |
Q2 2016 | 229.99 | 99.85 | 72.93 | 7.31 |
Q3 2016 | 224.32 | 89.88 | 62.16 | 2.72 |
Q4 2016 | 220.91 | 107.73 | 72.64 | 3.69 |
Q1 2017 | 242.80 | 104.89 | 71.94 | 4.27 |
Q2 2017 | 224.48 | 92.89 | 70.77 | 3.54 |
Q3 2017 | 133.39 | 85.39 | 60.16 | 3.27 |
Q4 2017 | 172.44 | 114.51 | 71.35 | 6.30 |
Q1 2018 | 214.32 | 109.10 | 68.50 | 3.20 |
Q2 2018 | 188.62 | 79.63 | 76.10 | 1.78 |
Q3 2018 | 184.16 | 98.93 | 53.64 | 2.04 |
Q4 2018 | 147.36 | 97.71 | 61.91 | 3.70 |
Q1 2019 | 181.07 | 97.28 | 67.29 | 4.54 |
Q2 2019 | 185.66 | 95.13 | 68.96 | 3.44 |
Q3 2019 | 223.51 | 95.92 | 64.81 | 2.51 |
Q4 2019 | 222.02 | 111.18 | 69.80 | 3.51 |
Q1 2020 | 264.27 | 98.09 | 71.34 | 2.60 |
Period | Inpatient clinics | Outpatient clinics | Pharmacy Sales | Others |
---|---|---|---|---|
2013 | - | - | 159.08 | 1.19 |
2014 | 807.92 | 323.31 | 257.32 | 10.20 |
2015 | 857.25 | 383.67 | 277.02 | 16.59 |
2016 | 916.44 | 397.66 | 280.76 | 20.77 |
2017 | 773.12 | 397.68 | 274.21 | 17.38 |
2018 | 734.45 | 385.37 | 260.14 | 10.73 |
2019 | 812.27 | 399.51 | 270.86 | 14.01 |
Item | Q1 2020 (e) | Q1 2020 (a) | Change |
---|---|---|---|
Average | 13.87 | 21.18 | 52.75 % |
Item | Q1 2020 (e) | Q1 2020 (a) | Change |
---|---|---|---|
OSOOL AND BAKHEET | 21.20 | 21.18 | (0.1) % |
SNB Capital | 14.00 | 21.18 | 51.3 % |
AlJazira Capital | 6.40 | 21.18 | 231.0 % |
Current | |
Market Cap (M Riyal) | 6,488.82 |
Enterprise Value (EV) (M) | 8,884.32 |
Shares Outstanding ((M)) | 92.04 |
EPS ( Riyal) (TTM) | 2.30 |
Book Value (BV) ( Riyal) | 18.46 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 33.80 |
P/E (TTM) | 30.70 |
Price/book | 3.82 |
Return on Average Assets (%) (TTM) | 4.2 |
Return on Average Equity (%) (TTM) | 13.2 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}